More cost cuts sought from drug industry
The pharmaceutical industry has remained relatively unscathed so far in Washington?s effort to overhaul the nation's healthcare system. But despite the much publicized 10-year, $80 billion cost-saving promise the drug industry made to President Obama and the chairman of the Senate Finance Committee, some House leaders do not think the drug makers have given enough. President Obama seemed to agree during a nationally televised news conference focused on healthcare reform. He praised the pharmaceutical industry for making a hard commitment, but added "we might be able to get $100 billion out of them, or more."
- Senators Hear How Two-Midnight Rule Harms Patients, Hospitals
- 3 Management Lessons from a Supermarket Debacle
- Handshaking Spreads Germs. Get Over It.
- Healthcare Costs Start With What We Eat
- Medicare Advantage Carriers See 'No Choice' But to Accept Cuts
- IOM Identifies GME Problems, Calls for Finance Changes
- Hospitals Likely to Outsource ICD-10 at Launch
- Revenue Cycles Get a Boost from Simple JPEG Files
- Anatomy of 3 Health System Rebranding Efforts
- Physicians to Appeal 'Docs v. Glocks' Ruling in FL